Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Aceragen, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 32 | 19 | −13 |
| SharesConverted for a 1-for-17 split | 190.3K | 168.1K | −22.2K (−11.7%) |
| Value | $1.13M | $384.8K | −$744.9K (−65.9%) |
New holders (0)
Institutions that held Aceragen, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (13)
Institutions that held Aceragen, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Commonwealth Equity Services, LLC | 87,412 | $30.0K |
| Northern Trust Corp | 74,267 | $26.0K |
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $19.7K |
| Citadel Advisors LLC | 50,318 | $17.6K |
| Johnson Investment Counsel Inc | 42,128 | $14.7K |
| Wade G W & Inc | 35,000 | $12.0K |
| Renaissance Technologies LLC | 31,700 | $11.0K |
| Two Sigma Securities, LLC | 19,294 | $6.75K |
| Bank of New York Mellon Corp | 14,685 | $5.14K |
| Mariner, LLC | 12,312 | $4.00K |
| Cambridge Investment Research Advisors, Inc. | 10,806 | $4.00K |
| Ropes Wealth Advisors LLC | 10,217 | $3.58K |
| Simplex Trading, LLC | 2,274 | $0 |